Obstetrics virtual care company Babyscripts raised $12 million in the first round of a Series B investment that will enable the company to accelerate the roll out of its virtual maternity care tool platform to providers.
MemorialCare Innovation Fund led the investment and was joined by Philips and the CU Healthcare Innovation Fund. The new round of funding gives Babyscripts around $26 million raised to date, Babyscripts co-founder and president Juan Pablo Segura told TechCrunch.
We last checked in on Washington, D.C-based Babyscripts two years ago when Phillips led a $6 million investment into the company. A lot has happened since 2019, Segura said.
At the time, the company had one product and was working with hospitals and healthcare providers to distribute a medical device and mobile app to expecting mothers for monitoring blood pressure and providing neonatal care information.
Today, the company has multiple kits that can be targeted to patients, including blood pressure monitoring, weight and captured blood sugars. Babyscripts can automate 40% to 50% of prenatal care and alert doctors as health problems occur so that both mother and baby are healthy. At one physician site, use of Babyscripts helped open up close to 1,000 appointments in a year so obstetricians there could focus on higher-risk patients, Segura said.
It also has larger population health focuses — driven mainly by the pandemic — to help higher-risk expecting mothers with remote patient monitoring and virtual care, as well as work to solve health inequity issues.
More than 70% of patients using Babyscripts are on Medicaid, which may be the only safety net provider in the patient’s geography, Segura said. As a result, the company began forming partnerships with public health departments, managed Medicaid plans and providers, like Priva Health, so that Babyscripts could be paid for at the local level.
“Right now, one of the biggest challenges for a pregnant patient on Medicaid and working an hourly job is asking moms to choose between prenatal care and putting food on the table,” he added. “Fifty percent of maternal complications can be avoided, but a lot of these issues come from the fact that the model of delivery care hasn’t changed in 40 years. About 12% to 15% of deaths come from blood pressure complications. If we could monitor via Babyscripts or more coordinated care to get intervention faster, we could eliminate massive swaths of delivery events in maternity and reduce mortality events in this country.”
Amid the pandemic, Babyscripts saw enrollments grow 10x. Segura decided to go after a new round of funding to meet that need and opportunities that could be addressed. Babyscripts’s program is now being used by 75 health systems in 32 states, and the company is monitoring 250,000 women each year.
The company continues to receive inquiries from markets and payers that are looking to do more for pregnant patients, so Segura wants to be able to grow to meet that demand and invest in a go-to-market strategy to get its kits into as many hands as possible.
The new funding will also enable the company to release new features. It recently launched a mental health product and is developing a substance use disorder experience amid others, he said. Babyscripts is also working on a national level with payers and is building an infrastructure around that as well.
The company has 45 employees currently, and Segura expects to double that in the next 12 to 18 months in the areas of product, payer growth, clinical expertise, implementation and customer success. Babyscripts is also working toward being available in all 50 states and bringing in more public health departments and payers as partners to get more health systems working together, he added.
Meanwhile, Caleb Winder, managing director of MemorialCare Innovation Fund, said he was attracted to both Babyscripts’ outcomes data and addressing the high rates of complications in pregnancies. It also not only eliminates waiting for hours at the doctor’s office just to be seen for five minutes, but also closes some gaps in care, he added.
“One of the problems in this space is that providers, as much as they want to help, are stretched thin,” Winder said. “There are also access problems. Something like 50% of counties in this country lack one OB, so in-person care is difficult. Babyscripts can help patients anywhere be monitored and their health managed virtually. It can also alert a clinician when there is a real problem. We saw their data, for example, that showed preeclampsia was diagnosed 13 days faster than the standard of care.”